Gender differences in schizophrenia

Psychoneuroendocrinology

Volumn 28, Issue SUPPL. 2, 2003, Pages 17-54

  Hafner H ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Gender difference in schizophrenia onset; Oestrogen substitution in schizophrenia; Post menopausal schizophrenia; Protective effect of oestrogen; Schizophrenia; Sex differences

Indexed keywords

ESTROGEN; NEUROLEPTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MORPHOLOGY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SCHOOL CHILD; SEX DIFFERENCE; SOCIAL EVOLUTION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0037376939     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(02)00125-7     Document Type: Article

References (164)

1. Addington D., Addington P., Patten S. Gender and affect in schizophrenia. Can. J. Psychiatry. 41:1996;265-268.
2. Albus M., Maier W. Lack of gender differences in age at onset in familial schizophrenia. Schizophr. Res. 18:1995;51-57.
3. Anderson J.C., Williams S., McGee R., Silva P.A. DSM-III disorders in preadolescent children: prevalence in a large community sample. Arch. Gen. Psychiatry. 44:1987;69-76.
4. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS). 1983;University of Iowa, Iowa City.
5. Adreasen N.C., Ehrhardt J.C., Swayze V.W., Alliger R.J., Yuh W.T.C., Cohen G., et al. Magnetic resonance imaging of the brain in schizophrenia: the pathophysiologic significance of structural abnormalities. Arch. Gen. Psychiatry. 47:1990;35-44.
6. Angermeyer M.C., Kühn L. Gender differences in age at onset of schizophrenia. Eur. Arch. Psychiatry Neurol. Sci. 237:1988;351-364.
7. Angermeyer M.C., Kühn L., Goldstein J.M. Gender and the course of schizophrenia: differences in treated outcomes. Schizophr. Bull. 16:1990;293-307.
8. Diagnostic and Statistical Manual of Mental Disorders. third ed. 1987;American Psychiatric Association, Washington, DC.
9. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. Revised: 1994;American Psychiatric Association, Washington, DC.
10. Bardenstein K.K., McGlashan T.H. Gender differences in affective, schizoaffective, and schizophrenic disorders. Schizophr. Res. 3:1990;159-172.
11. Biehl H., Maurer K., Jablensky A., Cooper J.E., Tomov T. The WHO psychological impairments rating schedule (WHO/PIRS). I. Introducing a new instrument for rating observed behaviour and the rationale of the psychological impairment concept. Br. J. Psychiatry. 155:1989;68-70.
12. Biehl H., Maurer K., Schubart C., Krumm B., Jung E. Predictin of outcome and utilization of medical services in a prospective study of first onset schizophrenics - results of a prospective 5-year follow-up study. Eur. Arch. Psychiatry Neurol. Sci. 236:1986;139-147.
13. Bland R.C. Demographic aspects of functional psychoses in Canada. Acta Psychiatr. Scand. 55:1977;369-380.
14. Bogerts B., Ashtari M., Degreef G., Alvis J.M.J., Bilder R.M., Lieberman J.A. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res. Neuroimag. 35:1990;1-13.
15. Campball S.B. Behavior Problems in Preschool Children. 1990;Guilford, New York.
16. Cannon T.C., Mednick S.A. The schizophrenia high risk project in Copenhagen: three decades of progress. Acta Psychiatr. Scand. 370:(Suppl. 370):1993;33-47.
17. Cannon T.D., Mednick S.A., Parnas J., Schulsinger F., Praestholm J., Vestergaard A. Developmental brain abnormalities in the offspring of schizophrenic mothers: I. Contributions of genetic and perinatal factors. Arch. Gen. Psychiatry. 50:1993;551-564.
18. Castle D.J. Gender and age at onset in schizophrenia. Howard R., Rabins P., Castle D. Late Onset Schizophrenia. 1999;147-164 Wrightson Biomedical, Hampshire.
19. Castle D.J. Women and schizophrenia: an epidemiological perspective. Castle D.J., McGrath J., Kulkarni J. Women and Schizophrenia. 2000;19-34 Cambridge University Press, Cambridge.
20. Castle D.J., Murray R.M. The neurodevelopmental basis of sex differences in schizophrenia. Psychol. Med. 21:1991;565-575.
21. Castle D.J., Murray R.M. The epidemiology of late-onset schizophrenia. Schizophr. Bull. 4:1993;691-699.
22. Castle D.J., Wessely S., Murray R.M. Sex and schizophrenia: effects of diagnostic stringency, and association with premorbid variables. Br. J. Psychiatry. 162:1993;658-664.
23. Choquet, M., Ledoux, S., 1994. Epidémiologie et adolescence. In: Confrontations Psychiatriques, vol. 27(35). Rhone-Poulenc rorer specia, Paris, pp. 287-309.
24. Cohen P., Cohen J., Kasen S., Velez C.N., Hartmark D., Johnson J., et al. An epidemiological study of disorders in late childhood and adolescence, I: age and gender specific prevalence. J. Child Psychol. Psychiatry. 34:1993;851-867.
25. Crow T.J. Syndromes of schizophrenia. Br. J. Psychiatry. 165:1994;721-727.
26. Crow T.J., Ball J., Bloom S.R., Brown R., Bruton C.J., Colter N., et al. Schizophrenia as an anomaly of development of cerebral asymmetry. A post-mortem study and a proposal concerning the genetic basis of the disease. Arch. Gen. Psychiatry. 46:1989;1145-1146.
27. Crow T.J., Done D.J., Sacker A. Birth cohort study of the antecedents of psychosis: ontogeney as witness to phylogenetic origins. Häfner H., Gattaz W.F. Search for the Causes of Schizophrenia, vol. III. 1995;3-20 Springer, Berlin, Heidelberg.
28. Dalton K. Menstruation and acute psychiatric illness. Br. Med. J. 1:1959;148-149.
29. Dickson R.A., Seeman M.V., Corenblum B. Hormonal side effects in women: typical versus atypical antipsychotic treatment. J. Clin. Psychiatry. 61:(Suppl. 3):2000;10-15.
30. DeLisi L.E., Bass N., Boccio A., Shilds G., Morganti C., Vita A. Age of onset in familial schizophrenia. Arch. Gen. Psychiatry. 51:1994;334-335.
31. DiPaolo T., Falardeau P. Modulation of brain and pituitary dopamine receptors by estrogens and prolactin. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 9:1985;473-480.
32. Döpfner M., Pluck J., Berner W., Fegert J.M., Huss M., Lenz K., et al. Psychische Auffälligkeiten von Kindern und Jugendlichen in Deutschland - Ergebnisse einer repräsentativen Studie: Methodik, Alters-, Geschlechts- und Beurteilereffekte (Mental disturbances in children and adolescents in Germany. Results of a representative study: age, gender and rater effects). Kinder Jugendpsychiat Psychother. 25:1997;218-233.
33. Earls F. Sex differences in psychiatric disorders: origins and developmental influences. Psychiatr. Dev. 1:1987;1-23.
34. Eaton W.W., Thara R., Federman B., Melton B., Liang K. Structure and course of positive and negative symptoms in schizophrenia. Arch. Gen. Psychiatry. 52:1995;127-134.
35. Endo M., Daiguji M., Asano Y., Yanashita I., Lakahashi S. Periodic psychosis occurring in association with the menstrual cycle. J. Clin. Psychiatry. 39:1978;456-461.
36. Erlenmeyer-Kimling L., Kestenbaum C., Bird H., Hilldoff U. Assessment of the New York high-risk project subjects in sample A who are now clinical deviants. Watt N., Anthony N., Wynne E.J., Rolf L.C. Children at Risk for Schizophrenia: A Longitudinal Perspective. 1984;Cambridge University Press, Cambridge.
37. Erlenmeyer-Kimling L., Cornblatt B.A., Rock D., Roberts S., Bell M., West A. The New York high-risk project: anhedonia, attentional deviance, and psychopathology. Schizophr. Bull. 19:1993;141-153.
38. Faraone S.V., Chen W.J., Goldstein J.M., Tsuang M.T. Gender differences in age at onset of schizophrenia. Br. J. Pychiatry. 164:1994;625-629.
39. Felthous A.R., Robinson D.B., Conroy R.W. Prevention of recurrent menstrual psychosis by an oral contraceptive. Am. J. Psychiatry. 137:1980;245-246.
40. Fennig S., Putnam K., Bromet E.J., Galambos N. Gender, premorbid characteristics and negative symptoms in schizophrenia. Acta Psychiatr. Scand. 92:1995;173-177.
41. Fields J.Z., Gordon J.H. Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics. Life Sci. 30:1982;229-234.
42. Fink G. The psychoprotective action of estrogen is mediated by central serotonergic as well as dopaminergic mechanisms. Takada A., Curzon G. Serotonin in the Central Nervous System and Periphery. 1995;175-187 Elsevier Science, BV, Holland.
43. Fink G., Sumner B., McQueen J.K., Wilson H., Rose R. Sex steroid control of mood, mental state and memory. Clin. Exp. Pharmacol. Physiol. 25:1998;764-765.
44. Fitzgerald P., Seeman M.V. Women and schizophrenia: treatment implications. Castle D.J., McGrath J., Kulkarni J. Women and Schizophrenia. 2000;95-110 Cambridge University Press, Cambridge.
45. Flaum M., Swayze V.W., O'Leary D.S., Yuh W.T., Ehrhardt J.C., Arndt S.V., et al. Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia. Am. J. Psychiatry. 152:1995;704-714.
46. Folnegovic Z., Folnegovic-Smalz V. Schizophrenia in Croatia: age of onset differences between males and females. Schizophr. Res. 14:1994;83-91.
47. Gattaz W.F., Behrens S., De Vrie J., Häfner H. Östradiol hemmt Dopamin-vermittelte Verhaltensweisen bei Ratten - ein Tiermodell zur Untersuchung der geschlechtsspezifischen Unterschiede bei der Schizophrenie. Fortschr. Neurol. Psychiatr. 60:1992;8-16.
48. Geddes J., Lawrie S. Obstetric complications and schizophrenia: a meta-analysis. Br. J. Psychiatry. 167:1995;786-793.
49. Goldberg T.E., Gold J.M., Torrey E.F., Weinberger D.R. Lack of sex differences in the neuropsychological performance of patients with schizophrenia. Am. J. Psychiatry. 152:1995;883-888.
50. Goldstein J.M. Gender differences in the course of schizophrenia. Am. J. Psychiatry. 145:1988;684-689.
51. Goldstein J.M. Impact of sampling biases in explaining discrepancies in studies on gender and schizophrenia: a reply. Schizophr. Bull. 19:1993;9-14.
52. Goldstein J.M. The impact of gender on understanding the epidemiology of schizophrenia. Seeman M.V. Gender and Psychopathology. 1995;159-199 American Psychiatric Press, Washington, DC.
53. Goldstein J.M. Gender and the famial transmission of schizophrenia. Seeman M.V. Gender and Psychopathology. 1995;American Psychiatric Press, Washington, DC.
54. Goldstein J.M. Sex and brain abnormalities in schizophrenia: fact or fiction? Harvard Rev. Psychiatry. 4:1996;110-115.
55. Goldstein J.M., Lewine R.R.J. Overview of sex differeces in schizophrenia: where have we been and where do we go from here? Castle D.J., McGrath J., Kulkarni J. Women and Schizophrenia. 2000;111-143 Cambridge University Press, Cambridge.
56. Goldstein J.M., Link B.G. Gender and the expression of schizophrenia. J. Psychiatr. Res. 22:1988;141-155.
57. Gomez R., Harvey J., Quick C., Scharer I., Harris G. DSM-IV AD/HD: confirmatory factor models, prevalence and gender and age differences based on parent and teacher ratings of Australian primary school children. J. Child Psychol. Psychiatry. 40:1999;265-274.
58. Gur R.C., Mozley L.H., Mozley P.D., Resnick S.M., Karp J.S., Alavi A., et al. Sex differences in regional cerebral metabolism during a resting state. Science. 267:1995;528-531.
59. Gur R.E., Gur R.C. Gender differences in regional cerebral blood flow. Schizophr. Bull. 16:1990;247-254.
60. Gur R.E., Mozley P.D., Resnick S.M., Shtasel D., Kohn M., Zimmerman R., et al. Magnetic resonance imaging in schizophrenia: I. Volumetric analysis of brain and cerebrospinal fluid. Arch. Gen. Psychiatry. 48:1991;407-412.
61. Häfner H. Epidemiology of schizophrenia. Häfner H., Gattaz W.F., Janzarik W. Search for the Causes of Schizophrenia. 1987;47-74 Springer, Berlin.
62. Häfner H. The epidemiology of onset and early course of schizophrenia. Häfner H., Wolpert E.M. New Research in Psychiatry. 1996;33-60 Hogrefe and Huber Publishers, Seattle, Toronto.
63. Häfner H. Ist es einzig die Krankheit? Möller H.-J., Müller N. Schizophrenie - Moderne Konzepte zu Diagnostik, Pathogenese und Therapie. 1998;37-59 Springer, Wien.
64. Häfner H. Gender differences in schizophrenia. Frank E. Gender and its Effects on Psychopathology. American Psychopathological Association Series. 2000;187-228 American Psychiatric Press, Washington, DC.
65. Häfner H., an der Heiden W. Epidemiology of schizophrenia. Can. J. Psychiatry. 42:1997;139-151.
66. Häfner H., Nowotny B. Epidemiology of early-onset schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 245:1995;80-92.
67. Häfner H., Behrens S., de Vry J., Gattaz W.F., Löffler W., Maurer K., et al. Warum erkranken Frauen später an Schizophrenie? Nervenheilkunde. 10:1991;154-163.
68. Häfner H., Riecher-Rössler A., Hambrecht M., Maurer K., Meissner S., Schmidtke A., et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr. Res. 6:1992;209-223.
69. Häfner H., Maurer K., Löffler W., Riecher-Rössler A. The influence of age and sex on the onset and early course of schizophrenia. Br. J. Psychiatry. 162:1993;80-86.
70. Häfner H., Riecher-Rössler A., an der Heiden W., Maurer K., Fätkenheuer B., Löffler W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol. Med. 23:1993;925-940.
71. Häfner H., Maurer K., Löffler W., Bustamante S., an der Heiden W., Riecher-Rössler A., et al. Onset and early course of schizophrenia. Häfner H., Gattaz W.F. Search for the causes of schizophrenia. vol. III:1995;43-66 Springer, Berlin, Heidelberg.
72. Häfner H., Maurer K., Löffler W., Nowotny B. Der Frühverlauf der Schizophrenie. ZMP. 5:1996;22-31.
73. Häfner H., Hambrecht M., Löffler W., Munk-Jorgensen P., Riecher-Rössler A. Is schizophrenia a disorder of all ages? A comparison of first episodes and early course over the life-cycle. Psychol. Med. 28:1998;351-365.
74. Häfner H., an der Heiden W., Behrens S., Gattaz W.F., Hambrecht M., Löffler W., et al. Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr. Bull. 24:1998;99-113.
75. Häfner H., an der Heiden W., Löffler W., Maurer K., Hambrecht M. Beginn und Frühverlauf schizophrener Erkrankungen. Klosterkötter J. Frühdiagnostik und Frühbehandlung Psychischer Störungen. 1998;1-28 Springer, Berlin, Heidelberg, New York. (Bayer-ZNS-Symposium, Bd. XIII.).
76. Häfner H., Löffler W., Maurer K., Riecher-Rössler A., Stein A. Instrument für die retrospektive Erfassung des Erkrankungsbeginns und verlaufs bei Schizophrenie und anderen Psychosen. 1999;Huber, Bern.
77. Häfner H., Maurer K., Löffler W., an der Heiden W., Stein A., Könnecke R., et al. Onset and prodromal phase and determinants of the course. Gattaz W.F., Häfner H. Search for the Causes of Schizophrenia. Vol. IV. Balance of the Century. 1999;35-58 Springer, Berlin, Heidelberg, Steinkopff, Darmstadt.
78. Häfner H., Löffler W., Riecher-Rössler A., Häfner-Ranabauer W. Schizophrenie und Wahn im höheren und hohen Lebensalter. Nervenarzt. 72:2001;347-357.
79. Hallonquist J.D., Seeman M.V., Lang M., Rector N.A. Variaton in symptom severity over the menstural cycle of schizophrenics. Biol. Psychiatry. 33:1993;207-209.
80. Hambrecht M., Maurer K., Sartorius N., Häfner H. Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders. Eur. Arch. Psychiatry Clin. Neurosci. 242:1992;6-12.
81. Hambrecht M., Riecher-Rössler A., Fätkenheuer B., Louza M.R., Häfner H. Higher morbidity risk for schizophrenia in males: fact or fiction? Compr. Psychiatry. 35:1994;39-49.
82. Harrison G., Croudace T., Mason P., Glazebrook C., Medley I. Predicting the long-term outcome of schizophrenia. Psychol. Med. 26:1996;697-705.
83. Hegarty J.D., Baldessarini R.J., Tohen M., Waternaux C., Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am. J. Psychiatry. 151:1994;1409-1416.
84. an der Heiden W., Krumm B., Müller S., Weber I., Biehl H., Schäfer M. Mannheimer Langzeitstudie der Schizophrenie. Nervenarzt. 66:1995;820-827.
85. an der Heiden W., Krumm B., Müller S., Weber I., Biehl H., Schäfer M. Eine prospektive Studie zum Langzeitverlauf schizophrener Psychosen: Ergebnisse der 14-Jahres-kiatamnese. ZMP. 5:1996;66-75.
86. Heimbuch R.C., Matthysse S.W., Kidd K.K. Estimating age-of-onset distributions for disorders with variable onset. Am. J. Hum. Genet. 32:1980;564-574.
87. Hruska, R.E., 1986. Evaluation of striatal dopamine receptors by estrogen: Dose and time studies, J. Neurochem. 47, 1908-1915.
88. Isohanni M., Rantakallio P., Jones P., Järvelin M.R., Isohanni I., Mäkikyrö T., et al. The predictors of schizophrenia in the 1966 northern Finland birth cohort study. Schizophr. Res. 29:1998;11.
89. Isohanni M., Järvelin M.-R., Nieminen P., Jones P., Rantakallio P., Jokelainen J., et al. School performance as a predictor of psychiatric hospitalization in adult life. A 28-year follow-up in the northern Finland 1966 birth cohort. Psychol. Med. 28:1998;967-974.
90. Jablensky A. Schizophrenia: the epidemiological horizon. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;206-252 Blackwell Science, Oxford.
91. Jablensky A., Sartorius N., Ernberg G., Anker M., Korten A., Cooper J.E., et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine Monograph. Suppl. 20:1992;Cambridge University Press, Cambridge.
92. Jenkins R., Bebbington P., Brugha T., Farrell M., Gill B., Lewis G., et al. The national psychiatric morbidity survey of Great Britain. Psychol. Med. 27:1997;765-774.
93. Jeste D.V., Lindamer L.A., Evans J., Lacro J.P. Relationship of ethnicity and gender to schizophrenia and pharmacology of neuroleptics. Psychopharmacol. Bull. 32:1996;243-251.
94. Jones P.B., Murray R.M., Rodgers B. Childhood risk factors for adult schizophrenia in a general population birth cohort at age 43 years. Mednick S.A., Hollister J.M. Neural Development in Schizophrenia. 1995;151-176 Plenum Press, New York.
95. Jones P.B., Rantakallio P., Hartikainen A.L., Isohanni M., Sipilä P. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 North Finland general population birth cohort. Am. J. Psychiatry. 155:1998;355-364.
96. Jung E., Krumm B., Biehl H., Maurer K., Bauer-Schubart C. DAS - Mannheimer Skala zur Einschätzung Sozialer Behinderung. 1989;Beltz, Weinheim.
97. Kandel D.B. Gender differences in the epidemiology of substance dependence in the United States. Frank E. Gender and its Effects on Psychopathology. 2000;231-252 American Psychopathological Association, Washington, DC.
98. Kendler K.S., Walsh D. Gender and schizophrenia: results of an epidemiologically based family study. Br. J. Psychiatry. 167:1995;184-192.
99. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and twelve month prevalence of DSM-III-R psychiatric disorders in the United States. Arch. Gen. Psychiatry. 51:1994;8-19.
100. Könnecke R., Häfner H., Maurer K., Löffler W., an der Heiden W. Main risk factors for schizophrenia: increased familial loading and pre- and perinatal complications antagonize the protective effect of oestrogen in women. Schizophr. Res. 44:2000;81-93.
101. Kraak B., Nord-Rüdiger D. Der Fragebogen zu Lebenszielen und zur Lebenszufriedenheit (FLL). 1989;Hogrefe, Göttingen.
102. Kraepelin E. eighth ed. Psychiatrie. vols. 1-4:1909;Barth, Leipzig.
103. th edition. Körperbau und Charakter. 1921;Springer, Berlin, Heidelberg.
104. Kulkarni J., de Castella A., Smith D., Taffe J., Keks N., Copolov D. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr. Res. 20:1996;247-252.
105. Kulkarni J., Gostt K., de Castella A. The menstrual cycle in women with schizophrenia. Schizophr. Res. 18:1996;254.
106. Kulkarni J., de Castella A., Taffe J., Burger H., Reidel A. Clinical estrogen trials in patients with schizophrenia. Curr. Opin. Psychiatry. 12:(Suppl. 1):1999;184-185.
107. Kulkarni, J., de Castella, A., Downey, M., Hammond, J., Reidel, A., Ward, S., et al., in press. Clinical estrogen trials in schizophrenia. In: Häfner, H., (Ed.), Risk and Protective Factors in Schizophrenia - Towards a Conceptual Model of the Disease Process. Steinkopff, Verlag, Berlin, Heidelberg, New York, Darmstadt.
108. Lauriello J., Hoff A., Wieneke M.H., Blankfeld H., Faustman W.O., Rosenbloom M., et al. Similar extent of brain dysmorphology in serverely ill women and men with schizophrenia. Am. J. Psychiatry. 154:1997;819-825.
109. Leboyer M., Filteau M.-J., Jay M., Campion D., Rochert T., D'Amato T., et al. No gender effect on age of onset in familial schizophrenia? Am. J. Psychiatry. 149:1992;1409.
110. Lehman A.F. The well-being of chronic mental patients. Arch. Gen. Psychiatry. 40:1983;369-375.
111. Lehman A.F. The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Eval. Prog. Plan. 6:1983;143-151.
112. Lewine R.J. Sex differences in age of symptom onset and first hospitalization in schizophrenia. Am. J. Orthopsychiatry. 50:1980;316-322.
113. Lewine R.R.J. Gender and schizophrenia. Nasrallah H.A. Handbook of Schizophrenia. vol. 3:1988;389-397 Elsevier, Amsterdam.
114. Lewine R.R.J., Seeman M.V. Gender, brain and schizophrenia: anatomy of differences/differences of anatomy. Seeman M.V. Gender and Psychopathology. 1995;131-158 American Psychiatric Press, Washington, DC.
115. Lewine R.R.J., Burback D., Meltzer H.Y. Effect of diagnostic criteria on the ratio of male to female schizophrenic patients. Am. J. Psychiatry. 141:1984;84-87.
116. Lewine R., Haden C., Caudle J., Shurett R. Sex-onset effects on neuropsychological function in schizophrenia. Schizophr. Bull. 23:1997;51-61.
117. Lewis S. Sex and schizophrenia: vive la difference. Br. J. Psychiatry. 161:1992;445-450.
118. Löffler W., Häfner H., Fätkenheuer B., Maurer K., Riecher-Rössler A., Lützhøft J., et al. Validation of Danish case register diagnosis for schizophrenia. Acta Psychiatr. Scand. 90:1994;196-203.
119. Loranger A.W. Sex difference in age of onset of schizophrenia. Arch. Gen. Psychiatry. 41:1984;157-161.
120. Maccoby E.E., Jacklin C.N. The Psychology of Sex Differences. 1974;Stanford University Press, Stanford.
121. McGlashan T.H., Bardenstein K.K. Gender differences in affective, schizoaffective, and schizophrenic disorders. Schizophr. Bull. 16:1990;319-329.
122. McGlone J. Sex differences in human brain asymmetry: a critical survey. Behav. Brain Sci. 3:1989;215-263.
123. McEwen B.S., Biegon A., Rainbow T.C., Paden C., Snyder L., DeGroff V. The interaction of estrogens with intracellular receptors and with putative neurotransmitter receptors: implications for the mechanisms of activation of regulation of sexual behaviour and ovulaton. Fuxe K., Gustafsson J.A., Wetterberg L. Steroid Hormone Regulation of the Brain. 1981;15-29 Pergamon Press, New York.
124. Mendelson W.B., Gillin J.C., Wyatt R.J. Sexual physiology and schizophrenia. Acta Scientifica Venezolana. 28:1977;417-425.
125. Moldin S.O. Gender and schizophrenia: an overview. Frank E. Gender and Its Effects on Psychopathology. 2000;169-186 American Psychiatric Press, Washington, DC.
126. Mueser K.T., Bellack A.S., Morrison R.L., Wixted J.T. Social competence in schizophrenia: premorbid adjustment, social skill, and domains of functioning. J. Psychiatr. Res. 24:1990;51-63.
127. Mueser K.T., Yarnold P.R., Levinson D.F., Singh H., Bellack A.S., Kee K., et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr. Bull. 16:1990;31-56.
128. Mueser K.T., Yarnold P.R., Bellack A.S. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta. Psychiatr. Scand. 85:1992;48-55.
129. Nasrallah R., Schwartzkopf S.B., Olson S.C., Coffman J.A. Gender differences in schizophrenia on MRI brain scans. Schizophr. Bull. 16:1990;205-210.
130. Opjordsmoen S. Long-term clinical outcome of schizophrenia with special reference to gender differences. Acta Psychiatr. Scand. 83:1991;307-313.
131. Parnas J., Cannon T.D., Jacobsen B., Schulsinger H., Schulsinger F., Mednick S.A. Lifetime DSM-IIIR diagnostic outcomes in offspring of schizophrenic mothers: results from the Copenhagen high-risk study. Arch. Gen. Psychiatry. 50:1993;707-714.
132. Pearlin L.I., Lieberman M.A., Menaghan E., Mullan J.T. The stress process. J. Health Soc. Behav. 22:1981;337-356.
133. Reite M., Teale P., Goldstein L., Whalen J., Linnville S. Late auditory magnetic sources may differ in the left hemisphere of schizophrenic patients. Arch. Gen. Psychiatry. 46:1989;565-572.
134. Reite M., Cullum C.M., Stocker J., Teale P., Kozora E. Neuropsychological test performance and MEG-based brain lateralization: sex differences. Br. Res. Bull. 32:1993;325-328.
135. Richman N., Stevenson J., Graham P. Preschool to School: A Behavioural Study. 1982;Academic Press, London.
136. Riecher-Rössler A., Häfner H. Schizophrenia and oestrogens - is there an association? Eur. Arch. Psychiatry Clin. Neurosci. 242:1993;323-328.
137. Riecher-Rössler A., Häfner H., Stumbaum M., Maurer K., Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophr. Bull. 20:1994;203-214.
138. Riecher-Rössler A., Häfner H., Dütsch-Strobel A., Oster M., Stumbaum M., van Gülick-Bailer M., et al. Further evidence for a specific role of estradiol in schizophrenia? Biol. Psychiatry. 36:1994;492-495.
139. Rosenfield S. Gender and dimensions of the self: implications for internalizing and externalizing behavior. Frank E. Gender and Its Effects on Psychopathology. American Psychopathological Association Series. 2000;23-36 American Psychiatric Press, Washington, DC.
140. Salokangas R.K.R., Stengard E., Räkköläinen V., Kaljonen I.H.A. New schizophrenic patients and their families (English summary). Reports of Psychiatria Fennica, No. 78. 1987;119-216 Foundation for Psychiatric Research in Finland.
141. Schultze-Lutter, F., Löffler, W., Häfner, H., in press. Testing models of the early course of schizophrenia. In: Häfner, H., (Ed.), Risk and Protective Factors in Schizophrenia - Towards a Conceptual Model of the Disease Process. Steinkopff, Verlag, Berlin, Heidelberg, New York, Darmstadt.
142. Seeman M.V. Gender and the onset of schizophrenia: neuro-humoral influences. Psychiatr. J. Univ. Ottawa. 6:1981;136-138.
143. Seeman M.V. Gender differences in schizophrenia. Can. J. Psychiatry. 27:1982;107-112.
144. Seeman M.V. Interaction of sex, age and neuroleptic dose. Compr. Psychiatry. 24:1983;125-128.
145. Seeman M.V. Prenatal gonadal steroids and schizophrenia. Psychiatr. J. Univ. Ottawa. 14:1989;473-475.
146. Seeman M.V. Neuroleptic prescription for men and women. Social Pharmacol. 3:1989;219-236.
147. Seeman M.V. The role of estrogen in schizophrenia. J. Psychiatry Neurosci. 21:1996;123-127.
148. Seeman M.V., Cohen R. Puberty and schizophrenia. Lopéz-Ibor J.L., Sartorius N., Gaebel W., Haasen C. Abstracts of the XI World Congress of Psychiatry, Hamburg, Germany, 6-11 August, 1999, Vol. I. Curr. Opin. Psychiatry. 12:(Suppl. 1):1999;6-11.
149. Seeman M.V., Lang M. The role of estrogens in schizophrenia gender differences. Schizophr. Bull. 16:1990;185-194.
150. Shimizu A., Kurachi M., Noda M., Yamaguchi N., Torii H., Jsaki K. Influence of sex on age at onset of schizophrenia. Jpn. J. Psychiatry Neurol. 42:1988;35-40.
151. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor and X and B MRNA in the rat central nervous system. J. Compr. Neurol. 388:1997;507-525.
152. Soyka M. Sucht und Schizophrenie. Nosologische, klinische und therapeutische Fragen. 1. Alkoholismus und Schizophrenie. Fortschr. Neurol. Psychiatr. 62:1994;71-87.
153. Sumner B.E.H., Fink G. Oestradiol-17β in its positive feedback mode significantly increases 5-HT2a receptor density in the frontal, cingulate and piriform cortex of the female rat. J. Physiol. 483:1995;52.
154. 2A receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Mol. Brain Res. 73:1999;119-128.
155. Van Os J., Howard R., Takei N., Murray R. Increasing age is a risk factor for psychosis in the elderly. Soc. Psychiatry Psychiatr. Epidemiol. 30:1995;161-164.
156. Walker E.F., Weinstein J., Baum K., Neumann C.S. Antecedents of schizophrenia: moderating effects of development and biological sex. Häfner H., Gattaz W.F. Search for the Causes of Schizophrenia. vol. III:1995;21-42 Springer, Berlin, Heidelberg.
157. Watt N.F., Grubb T.W., Erlenmeyer-Kimling L. Social, emotional, and intellectual behavior at school among children at high risk for schizophrenia. Watt N.F., Anthony J., Wynne L.C., Rolf L.C. Children at High Risk for Schizophrenia. 1984;212-226 Cambridge University Press, London.
158. Weber, I., 1996. Lebenszufriedenheit einer Kohorte Schizophrener 15,5 Jahre nach stationärer Aufnahme. Doctoral thesis for a Doctor scientiarum humanarum of the Mannheim Faculty of Clinical Medicine of the Ruprecht Karls University of Heidelberg.
159. Weiser M., Reichenberg A., Rabinowitz J., Kaplan Z., Mark M., Nahon D., et al. Gender differences in premorbid cognitive performance in a national cohort of schizophrenic patients. Schizophr. Res. 45:2000;185-190.
160. Follow-Up History Schedule (WHO/FU-HSD). 1980;WHO, Geneva.
161. Psychiatric Disability Assessment Schedule (WHO/DAS). 1988;WHO, Geneva.
162. Wing J.K., Cooper J.E., Sartorius N. Measurement and Classification of Psychiatric Symptoms: An Instruction Manual for the PSE and CATEGO Program. 1974;Cambridge University Press, London.
163. Witelson S.F. Hand and sex differences in the isthmus and genu of the human corpus callosum. Brain. 112:1989;799-835.
164. Woolley C.S., McEwen B.S. Estradiol regulates hippocampal dendritic spine density via an N-Methyl-D-aspartate receptor-dependent mechanism. J. Neurosci. 14:1994;7680-7687.